Cargando…
Hypertrophic cardiomyopathy in a lupus patient: a case of hydroxychloroquine cardiotoxicity
Hydroxychloroquine (HCQ) is a well‐established and effective immunomodulatory therapy for systemic lupus erythematosus and other autoimmune diseases. While retinal toxicity is a well‐recognized complication, cardiotoxicity is lesser known. This case consists of a 63‐year‐old Filipina on chronic HCQ...
Autores principales: | Chang, Amanda, Stolin, Gabriel, Fan, Judith, Larreta, Boris R., Fishbein, Gregory A., Wallace, William Dean, Baas, Arnold S., Cruz, Daniel, Wang, Jessica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989295/ https://www.ncbi.nlm.nih.gov/pubmed/31493341 http://dx.doi.org/10.1002/ehf2.12508 |
Ejemplares similares
-
Cardiotoxicity of chloroquine and hydroxychloroquine through mitochondrial pathway
por: Seydi, Enayatollah, et al.
Publicado: (2023) -
Chloroquine or Hydroxychloroquine for COVID‐19: Is Cardiotoxicity a Concern?
por: Kamp, Timothy J., et al.
Publicado: (2020) -
Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020) -
Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023) -
Review of Hydroxychloroquine Cardiotoxicity: Lessons From the COVID-19 Pandemic
por: Gagnon, Luke R., et al.
Publicado: (2022)